AECOM Investigation Notice: Levi & Korsinsky Notifies Investors of Pending Investigation Into AECOM (ACM)

AECOM investors were told adjusted EPS of $1.29 and a $5.95 full-year midpoint; the reported quarter came in at an adjusted loss of roughly $0.50 per share, and an investigation is pending into potential securities law violations.

A roughly $1.79-per-share gap now separates what AECOM (NYSE: ACM) told investors its adjusted earnings were and the adjusted loss of approximately $0.50 per share reported alongside a full-year outlook cut to about $4.05 at the midpoint. Investors who lost money on ACM shares are encouraged to submit their information.

On the February 10, 2026 earnings call, Chief Executive Officer Troy Rudd stated that "adjusted EBITDA of $287 million and adjusted EPS of $1.29 exceed our expectations." The quarter that drove the stock decline was reported at an adjusted loss of roughly $0.50 per share against consensus of approximately $1.46 to $1.51. The forward numbers moved the same direction. Chief Financial Officer and Chief Operating Officer Gaurav Kapoor said on that same call that the Company "now expect[s] adjusted EPS of $5.95 at the midpoint of our range as compared to $5.75 previously." The midpoint investors were later given was approximately $4.05 -- a difference of roughly $1.90 per share.

Shareholders who purchased ACM stock and suffered a loss may have their potential recovery reviewed at no charge.

AECOM shares declined after the Company reported revenue down approximately 14.2% year over year to roughly $3.59 billion, an adjusted loss of about $0.50 per share versus consensus near $1.46 to $1.51, and a full-year adjusted EPS outlook of approximately $4.05 at the midpoint. The investigation concerns whether AECOM made materially false or misleading statements regarding its adjusted earnings results and full-year adjusted EPS guidance, including statements that adjusted EPS reached new highs and that full-year profit guidance was being increased.

Investors who purchased ACM stock or securities and suffered financial losses may be eligible. Eligibility is based on purchase date and documented losses -- not on whether you still hold the shares.

Investors may gather brokerage records showing purchase dates, share quantities, and prices paid. Submit your information for a no-cost, no-obligation evaluation of your potential recovery. No immediate action is required to remain eligible to participate in the investigation.

Brokerage statements or trade confirmations showing purchase dates, share quantities, prices paid, and any subsequent sale dates and prices are needed to participate.

Yes. Eligibility is based on when you purchased, not whether you still hold the shares. Investors who bought ACM and sold at a loss may still participate in the investigation.

There is no upfront cost to submit your information and review whether you may be eligible to recover. Should you choose to participate in any resulting action, these matters are generally handled on a contingency basis, with any attorneys' fees and expenses subject to court approval.

No. Participating in the investigation does not require court appearances or depositions.